Business Context and Reporting Period
This Form 8-K is filed by Eyenovia, Inc. (not Hyperion Defi, Inc.) on May 15, 2024. The report announces the financial results for the fiscal quarter ended March 31, 2024. The company is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol EYEN.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release (Exhibit 99.1) for detailed data. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for specific financial figures.
Material Changes
The filing text does not contain specific data regarding material changes versus the prior comparable period. It only confirms the issuance of a press release detailing the Q1 2024 results.
Guidance, Outlook, and Risks
The document includes standard legal disclaimers stating that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated. No specific guidance, outlook, or risk factors are detailed within the text of this 8-K form itself.
Investor Verification Checklist
- Verify the discrepancy between the requested company name ("Hyperion Defi, Inc.") and the actual registrant ("Eyenovia, Inc.").
- Locate and review Exhibit 99.1 (the Press Release) to obtain actual revenue, net loss, and cash position figures.
- Confirm the specific clinical or operational milestones discussed in the referenced press release, as the 8-K text contains no operational details.
- Check the Nasdaq Capital Market listing status for ticker EYEN.